Zdrowie i gospodarka · 19/05/2016
FDA Renews Peripheral and Central Nervous System Drugs Advisory Committee for 2 Years
The FDA has renewed the Peripheral and Central Nervous System Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on June 4, 2018.
Source: Federal Register — Food and Drug AdministrationOpen original release →